Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02756390 · ClinicalTrials.gov registry record · NA

CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors

A NA study of Insomnia, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT02756390 is a NA study of Insomnia that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 56 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02756390, a NA study of Insomnia, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This research study is evaluating the effectiveness of a 3-session behavioral intervention for insomnia in cancer survivors. This is a behavioral intervention study, and no medications are involved.

Conditions Studied

Insomnia

Interventions

  • BEHAVIORAL Sleep Hygiene
  • BEHAVIORAL CBTI-CS
  • BEHAVIORAL CBTI-CS via Telehealth

Study Locations (1)

Massachusetts

  • Dana Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2015-12
Est. Completion 2018-05-14
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02756390

The ClinicalTrials.gov registry entry for NCT02756390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (67% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 3 interventions - of which Sleep Hygiene is the first listed.

NCT02756390 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02756390 about?

NCT02756390 is a clinical study titled "CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors". This research study is evaluating the effectiveness of a 3-session behavioral intervention for insomnia in cancer survivors. This is a behavioral intervention study, and no medications are involved.

What is the current status of trial NCT02756390?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2015-12. Estimated completion is 2018-05-14.

What conditions does trial NCT02756390 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT02756390?

The interventions under investigation include: Sleep Hygiene (BEHAVIORAL), CBTI-CS (BEHAVIORAL), CBTI-CS via Telehealth (BEHAVIORAL).

Who is sponsoring clinical trial NCT02756390?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02756390 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insomnia

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.